| 000 | 01516 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516065159.0 | ||
| 264 | 0 | _c20130710 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1573-9546 | ||
| 024 | 7 |
_a10.1007/s11302-011-9280-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKalhan, A | |
| 245 | 0 | 0 |
_aAdenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy. _h[electronic resource] |
| 260 |
_bPurinergic signalling _cJun 2012 |
||
| 300 |
_a265-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeuroendocrine Tumors _xdrug therapy |
| 650 | 0 | 4 |
_aPurinergic P1 Receptor Agonists _xpharmacology |
| 650 | 0 | 4 |
_aPurinergic P1 Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, Adenosine A2A _xbiosynthesis |
| 650 | 0 | 4 |
_aReceptor, Adenosine A2B _xbiosynthesis |
| 700 | 1 | _aGharibi, B | |
| 700 | 1 | _aVazquez, M | |
| 700 | 1 | _aJasani, B | |
| 700 | 1 | _aNeal, J | |
| 700 | 1 | _aKidd, M | |
| 700 | 1 | _aModlin, I M | |
| 700 | 1 | _aPfragner, R | |
| 700 | 1 | _aRees, D A | |
| 700 | 1 | _aHam, J | |
| 773 | 0 |
_tPurinergic signalling _gvol. 8 _gno. 2 _gp. 265-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11302-011-9280-5 _zAvailable from publisher's website |
| 999 |
_c21346149 _d21346149 |
||